BRD4 and renal cell carcinoma: In renal cell carcinoma, the BRD4 knockdown and JQ1 treatment suppressed the epithelial-to-mesenchymal transition (EMT) and tumor growth progression via caspase-1-dependent pyroptosis in vitro and in vivo [61].